Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Gadicke Ansbert
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   30,197    

Indirect Shares

   56,162,356      
Direct Value   $23,415    

Indirect Value

   $190,370,892      
Total Shares   56,192,553      
Total Value   $190,394,307      


Allovir Inc $23,415 Allovir Inc $23,415
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rigel Pharmaceuticals Inc RIGL Former 10% Owner 2004-07-02 0 2004-09-13 475,026    Premium*  
            Idenix Pharmaceuticals Inc IDIX Director, 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Radius Health Inc. RDUS Director 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Former 10% Owner 0 2013-03-11 2,790,479    Premium*  
            Verastem, Inc. VSTM Director 2012-02-01 0 2012-02-01 3,740    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 2012-06-05 0 2012-07-09 1,275,886    Premium*  
            Epizyme, Inc. EPZM 10% Owner 0 2014-02-10 2,413,819    Premium*  
            Aratana Therapeutics, Inc. PETX 10% Owner 2014-03-07 0 2014-03-07 3,388,165    Premium*  
            Chiasma, Inc CHMA Director, 10% Owner 2015-07-21 0 2015-07-21 5,681,544    Premium*  
            Harpoon Therapeutics, Inc. HARP 10% Owner 2019-02-12 0 2019-02-12 8,422,847    Premium*  
            Tcr2 Therapeutics Inc. TCRR Director, 10% Owner 2019-02-19 0 2023-06-01 0    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2021-07-12 3,882,485    Premium*  
            Allovir Inc ALVR Director, 10% Owner 2022-07-28 30,197 2022-07-28 16,674,766    Premium*  
            Dyne Therapeutics, Inc. DYN 10% Owner 2020-09-21 0 2020-09-21 91,081    Premium*  
            Oncorus, Inc. ONCR 10% Owner 0 2020-10-06 2,377,025    Premium*  
* Premium Members only  

Records found :    108         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-26 4 AS $32.74 $787,399 I/I (24,036) 4,248,623 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-03-15 4 A $0.00 $0 I/I 24,271 4,672,838 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-09-01 4 S $21.13 $517,719 I/I (24,500) 1,687,072 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-04-19 4 S $20.30 $507,500 I/I (25,000) 3,809,269 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-06-08 4 AS $32.80 $869,825 I/I (26,200) 4,118,225 0 -
PETX Aratana Therapeutics, Inc... 10% Owner   –       –       •   2014-03-07 4 S $20.16 $538,534 D/D (26,713) 0 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-20 4 S $21.84 $600,619 I/I (27,499) 1,772,925 -
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2012-06-05 4 S $0.29 $8,571 I/I (29,555) 3,791,585 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-22 4 S $15.51 $462,153 I/I (29,805) 3,461,158 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-06-17 4 AS $33.78 $1,099,039 I/I (32,518) 4,044,250 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-06-09 4 AS $34.42 $1,221,633 I/I (35,230) 4,082,995 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-06-21 4 AS $33.80 $1,296,858 I/I (37,588) 3,997,662 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-25 4 S $15.80 $861,182 I/I (54,500) 3,336,463 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-07-12 4 AS $33.58 $1,948,413 I/I (58,012) 3,882,485 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-08-31 4 S $20.60 $1,246,626 I/I (60,527) 1,711,572 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-24 4 S $15.54 $1,084,850 I/I (69,807) 3,390,963 -
TCRR Tcr2 Therapeutics Inc. Director   –       •       •   2023-05-22 4 S $1.88 $131,920 I/I (70,170) 304,001 0 %
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2012-07-02 4 S $0.29 $23,301 I/I (80,348) 3,669,887 0 -
SOMX Somaxon Pharmaceuticals, ... 10% Owner   –       –       •   2012-07-03 4 S $0.29 $28,481 I/I (98,210) 3,571,677 0 -
VSTM Verastem, Inc. Director   –       •      –    2012-02-01 4 B $10.00 $1,000,000 I/I 100,000 3,740 2.1 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-04-21 4 S $20.78 $2,778,605 I/I (133,698) 3,675,571 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-05-20 4 S $17.25 $2,402,857 I/I (139,313) 3,536,258 -
TCRR Tcr2 Therapeutics Inc. Director   –       •       •   2023-05-22 4 OE $0.74 $131,919 I/I 178,269 374,171 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-21 4 AS $34.80 $10,532,881 I/I (302,669) 4,301,431 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-04-08 4 S $19.93 $6,295,927 I/I (315,902) 3,834,669 -
  108  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us